Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

199.51 +0.02 (+0.01%)
Official Closing Price Updated: 8:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Monday Bloodbath
Today was one of the worst days for the stock market of the last few years. 
Via Talk Markets
Topics Stocks / Equities
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
Small caps took another step down this past week as geopolitical events dampened sentiment. 
Via Talk Markets
Topics ETFs Stocks / Equities
Americans Are Waking Up To The Consequences Of U.S. Tariffs Aimed At Canada
Americans are just now coming to grips with the implications for their economy of tariffs. 
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Economy
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Friday’s Reversal Should Bode Well For Equity Bulls/Volatility Bears N/T
The major US equity indices have now dropped for three weeks. Amidst this, last Friday’s action should bode well for the bulls – at least in the near term. 
Via Talk Markets
Topics Stocks / Equities
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?
Investor attention is now on whether Merck will confirm a formal offer as speculation over a potential acquisition continues dominating discussions around the stock. 
Via Stocktwits
Asana’s Retail Traders Remain On Wait-And-Watch Mode Ahead Of Q4 Results
Asana’s guidance issued in early December projected a bottom-line loss of $0.01-$0.02 per share and revenue of $187.5 million to $188.50 million. 
Via Stocktwits
March Came In Like A Lion - Key Sectors Are Looking For A Lamb
Looking at the monthly chart, XRT now sits back in economic contraction, or below the 23-month moving average. 
Via Talk Markets
Topics ETFs
One Week Is Currently Like A Decade In These Markets
It’s what they call a “low dollar market” in that general conditions aren’t easy and there aren’t many slam dunk no-brainer setups. 
Via Talk Markets
Topics ETFs Stocks / Equities
CoT: Peek Into Future Thru Futures, Hedge Fund Positioning
Non-commercials just switched to net long e-mini S&P 500 futures after remaining net short for 14 weeks in a row. They are likely to do well on this switch – at least near term. 
Via Talk Markets
Topics Bonds Currencies/Forex Stocks
Exposures US Equities
SPY Trying To Find A Floor At The 200 SMA; One New Swing
In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my... 
Via Talk Markets
Topics Stocks / Equities
Financial Markets Report For Friday, March 7
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Friday, March 7. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Powell Speech Calms Rattled Markets, Stocks Finish Higher
The markets closed a difficult week on an upbeat note. 
Via Talk Markets
Topics Stocks / Equities
Congressman Ditches Russell 2000 ETF To Buy Lithium, Uranium ETFs
Congress trading activity shows a new unusual transaction of a Senator buying uranium and lithium ETFs. 
Via Benzinga
Topics ETFs
Nasdaq Falls Into Correction As Tariffs Roil Wall Street: What's Moving Markets Friday?
All three major indices were red in Friday’s midday trading, with the S&P 500 and Nasdaq 100 down 1% and 1.24%, respectively, and on track for their worst weeks since September 2024. 
Via Benzinga
Heavy March Headwinds Continue: Stocks Market Indexes Down
No rest for the weary, folks. The stock market took another slide today, giving back yesterday’s nice gains — and then some. 
Via Talk Markets
Topics Stocks / Equities
Xeris Biopharma Stock Soars To Nearly 4-Year High On Strong 2025 Outlook, Retail Bulls Charge In
The company expects full-year revenue of $255 million to $275 million, significantly higher than the $239.77 million analysts had expected. 
Via Stocktwits
Financial Markets Report For Thursday, March 6
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Thursday, March 6. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Are Small-Cap Stocks A Buy After Russell 2000 Correction?
Investors are questioning the value of small-cap stocks, as reflected by Russell 2000's 15% drop. Some top stocks saw even bigger declines. 
Via Benzinga
Trade Turmoil, Oil Slides: What's Driving Markets Thursday?
All three major indices remain in the red midday Thursday, after trimming earlier losses which saw the Dow Jones down more than 600 points at session lows. The major averages lost more than 2% this... 
Via Benzinga
Topics Stocks
Exposures US Equities
Grindr’s Q4 Beat Fails To Impress As Investors Fret Over Slower Revenue Growth Forecast For 2025: Retail Shrugs Off Stock Plunge
The company said all user metrics reached record highs, reflecting its platform's strength and continued community engagement. 
Via Stocktwits
Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential
The company expects its current cash position and retained portions of payments from its agreement with Vertex to support operations into the second quarter of 2027. 
Via Stocktwits
Financial Markets Report For Wednesday, March 5
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Wednesday, March 5. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates
Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years. 
Via Stocktwits
Nasdaq, S&P 500 Bounce Back As Trump’s Tariff Pause Calms Markets
Via Talk Markets
Topics Government Stocks Stocks / Equities
Exposures Political US Equities
Upcoming "Death Cross" For Russell 2000
There was some modest buying today from the open, but volume was light and markets are below trading range support established during the latter part of 2024. 
Via Talk Markets
Topics Stocks / Equities
Wall Street Awaits Trump's Tariff Decision, Digests Mixed Economic Data: What's Driving Markets Wednesday?
The three major indices were mostly flat in midday trading Wednesday with the S&P 500 and Nasdaq slightly under the flatline and the Dow Jones up 39 points.  
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Trump Bump Turns Into A Slump: SPY Sinks As S&P 500 Erases Post-Election Gains
Small caps, once darlings of the so-called "Trump trade," are crumbling. The Russell 2000 soared 5.84% after Election Day. Now it's down 8%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy
The health agency has accepted Capricor's Biologics License Application for full approval of deramiocel as a treatment for Duchenne muscular dystrophy cardiomyopathy. 
Via Stocktwits
Exposures Product Safety
Financial Markets Report For Tuesday, March 4
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Tuesday, March 4. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.